Most Clicked StoriesMore >


Goodwin teams up with Minn. foundation to develop opioid addiction vaccines

BIO SmartBrief | Mar 23, 2017

Goodwin Biotechnology and the Minneapolis Medical Research Foundation have entered into a collaboration to develop Goodwin's two opioid addiction vaccines. A three-year grant from the National Institute on Drug Abuse will fund the research. BioPharmaReporter.com (03/22)


Regeneron teams up with Biobank, GSK to sequence gene data

BIO SmartBrief | Mar 24, 2017

Arbutus, Alexion sign licensing deal for rare disease mRNA drug

BIO SmartBrief | Mar 20, 2017

Allergan's longer-lasting gel for facial wrinkles wins FDA nod

BIO SmartBrief | Mar 21, 2017

Small farms find a lean way to stay competitive in tough market

BIO SmartBrief | Mar 20, 2017

Parkinson's disease drug from Newron wins FDA nod

BIO SmartBrief | Mar 22, 2017

CytomX adds immuno-oncology targets to deal with Bristol-Myers

BIO SmartBrief | Mar 21, 2017

Astellas partners with X-Chem on drug-discovery programs

BIO SmartBrief | Mar 21, 2017

X-Chem partners with Ono on cancer drug-discovery programs

BIO SmartBrief | Mar 22, 2017

Actinium gets EMA nod for AML drug

BIO SmartBrief | Mar 23, 2017


Find BIO SmartBrief Issues by Date:



BIO News More >


BIO 2017 World Congress

BIO SmartBrief | Mar 24, 2017

Register for BIO Talent Connect, BIO's Career Growth Opportunity at BIO 2017

BIO SmartBrief | Mar 24, 2017

Register for BIO's Executive Training courses

BIO SmartBrief | Mar 23, 2017

A better way to purchase office supplies and professional printing

BIO SmartBrief | Mar 23, 2017

Illumina -- New version for Latest

BIO SmartBrief | Mar 22, 2017




Sign up for BIO SmartBrief



Designed specifically for biotechnology industry professionals like you, BIO SmartBrief is a FREE daily e-mail newsletter. It provides the latest news and information you need to stay informed about important biotech issues. Learn more